FDA official discusses use of RWE in cancer research and approvals

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsNorth AmericaPharmaceuticalsPharmacovigilanceProject managementRegulatory Intelligence/Policy